Professor Michael G Hanna is a Consultant Neurologist and is also Clinical Director of the National Hospital for Neurology and Neurosurgery, Queen Square, part of UCLH NHS Foundation Trust.
He has a longstanding clinical and research interest in muscle diseases and is head of the Queen Square muscle disease clinical service. He is Director of the London-Newcastle MRC Centre for translational research in neuromuscular diseases-the central mission of the MRC Centre is to work closely with clinical and scientific colleagues across UCL and Newcastle to add value to basic science programmes and catalyse the pipeline from discovery to treatment. The centre has established new core activities to overcome gaps in translation, including a neuromuscular clinical trials centre, an animal model unit, a UK muscle cell-line biobank, an outcome measure activity which includes neuromuscular MRI and a translational research PhD programme.
Michael is a senior member of the North American Muscle Study Group-a consortium of scientific investigators who are committed to running controlled clinical trials for neuromuscular diseases. He is also corresponding member of the American Neurological association, member of the World Muscle Society and is a Guarantor of Brain.
Michael qualified in Medical Biochemistry and then in Medicine at the University of Manchester and undertook postgraduate medical and neurological training posts in Newcastle, Oxford and London. He was an MRC training fellow to Professor Anita Harding undertaking his medical doctorate research in the genetics of mitochondrial diseases. He became a consultant at the National Hospital and Senior Lecturer in the Institute of Neurology in 1997 and Professor in Clinical Neurology in 2006.
He has a long-standing research interest in elucidating molecular genetic mechanisms in mitochondrial diseases and muscle/neurological channelopathies and also in the development of improved genetic diagnostics. He leads the UK national diagnostic reference laboratory and advisory service for channelopathies and co-leads a similar service for mitochondrial diseases.
He has published over 170 peer reviewed original research papers including New England Journal of Medicine, American Journal of Human Genetics, Lancet Neurology and Lancet, and has held the position of deputy Editor of the Journal of Neurology, Neurosurgery and Psychiatry since 2003.